Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements with Certain Officers.

(b) Resignation of Brendan O'Grady, Executive Vice President - North America Commercial

Brendan O'Grady, Executive Vice President - North America Commercial, has submitted his resignation from Teva, effective August 15, 2021, in order to pursue other career opportunities.

Item 9.01 Financial Statements and Exhibits



(d) Exhibits

  Exhibit
    No.        Description of Document
                 Press Release issued by Teva Pharmaceutical Industries Ltd.
    99.1       dated July 21, 2021.



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses